Gilead pays Watertown startup Lyndra $123M to develop longer-lasting HIV pill
July 09, 2019 at 05:05 AM EDT
California-based Gilead Sciences Inc. is enlisting Watertown startup Lyndra Therapeutics to develop one or more HIV drugs that could last a week, allowing patients to take fewer pills.
